Home
Inanovate Spotlight
Image

Inanovate launches the i-Slide™ protein micro-array substrate platform.  "The best surfaces in the world for handling and working with proteins".  Click Here for more information about the i-Slide™ and our Free introductory trial for selected customers!
 

Our Mission

Inanovate's mission is to make accurate cancer screening available and affordable to everyone.

To achieve this mission, Inanovate combines proprietary nano-scale surface technologies, protein screening procedures, and protein biomarker content, with cutting edge expertise and facilities; to create advanced biochip systems for handling and working with proteins.

Products & Services

In addition to the development of clinical diagnostic systems, Inanovate offers a range of pre-clinical products and services designed to make protein biochip based research more accurate, more reliable and more cost effective. Our offerings include: The leading surfaces in the world for handling and working with proteins; Unique and powerful biomarker Screening and Validation procedures; and a wide variety of protein micro-array Services including protein printing/arraying, and assay development.

Our History

Inanovate was founded in 2005 by David Ure and David Arslanian. The company grew on a foundation provided by a unique nano-scale surface fabrication technology developed at the Nano-Scale Physics Research Laboratory at the University of Birmingham (UK). This novel approach to surface fabrication led to Inanovate’s first product, a protein biochip substrate platform called the i-Slide™

Read More

The i-Slide

Using proprietary nano-scale surface patterning technology, Inanovate has developed the leading surfaces in the world for handling and working with proteins. The i-Slide™ attaches proteins to a surface, controlling their densities, influencing their orientations, helping maintain their function, and thus optimizing assay performance. The i-Slide™ provides the ultimate in protein biochip technology for researchers requiring industry leading sensitivity, consistency and reproducibility.

Read More

The i-Screen

A low cost, disposable, diagnostic platform for the early detection and monitoring of cancer at the point of care. The i-Screen™ is designed to move the healthcare industry’s focus away from expensive, painful and often ineffective late stage cancer treatment, towards early stage diagnosis and lower impact, lower cost therapies.

Read More

Services

Inanovate has extensive protein arraying capabilities, housing fully automated sample handling systems, multiple state of the art protein arrayers, and multiple array and well based scanning and analysis systems. Leveraging these facilities and our industry leading protein micro-array expertise, Inanovate offers custom protein printing / arraying services, as well as fully integrated assay development services and support. Please contact our enquiries team for further details.

Read more

The i-Assay

Inanovate owns exclusive rights to a unique method of biomarker discovery, developed at Harvard Medical School, and based on a proprietary reverse capture assay procedure for the rapid and accurate screening of auto-antibody biomarkers. Inanovate has developed this system into a sophisticated biomarker screening platform called the i-Assay™.

Read More